The abstract is read at the publisher; the summary is JClub's.
A 39-year-old healthcare worker with Bundibugyo virus infection in Ituri Province, DRC, achieved viral clearance by day 13 after symptom onset under MBP134 plus remdesivir.
- Why it matters: Clinical data for BDBV infection are limited, and no approved virus-specific treatment exists, leaving uncertainty about virologic dynamics and immune responses during therapy.
- What they did: The patient received MBP134 under FDA eIND authorization with remdesivir and supportive care; viral RNA was tracked in oropharyngeal swabs, plasma, urine, stool, and semen.
- The result: Viral RNA became undetectable in blood, throat swabs, urine, and stool by day 13 and in semen by day 25, with recovery and discharge on day 22.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.